Decreased skin reactivity to codeine in patients with the acquired immunodeficiency syndrome.
To evaluate the skin reactivity and the mast cell releasibility in the acquired immunodeficiency syndrome (AIDS), 24 patients with AIDS were skin tested with histamine (1 mg/ml) and codeine phosphate (0.9, 0.09, and 0.009 mg/ml), a mast cell degranulating agent. They were compared to 12 HIV-negative healthy volunteers and 16 urticaria-prone subjects. Reactivity to codeine phosphate was lower in patients with AIDS than in HIV-negative subjects. This difference in skin reactivity was the more significant when the AIDS group was compared to the urticaria-prone group. There was no correlation between the reactivity to codeine and the IgE levels. Possible explanations to the decreased skin reacting to codeine in patients with AIDS include a decrease of local mast cell density or releasibility. This suggests that a mechanism related to urticaria and involving mast cells is quite unlikely to be at the origin of the hypersensitivity reactions observed in AIDS.
Simonart
T h
Th
Department of Dermatology, Erasme Hospital, University Hospital, Brussels, Belgium.
Parent
D
D
Heenen
M
M
Farber
C M
CM
Van Vooren
J P
JP
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000328:Adult; D016022:Case-Control Studies; D015550:Cell Degranulation / Q000187:drug effects / Q000276:immunology; D003061:Codeine / Q000009:adverse effects* / Q000276:immunology* / Q000494:pharmacology; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007428:Intradermal Tests; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology; D008875:Middle Aged; D012867:Skin / Q000276:immunology*; D014581:Urticaria / Q000276:immunology
D007073:Immunoglobulin E; D006632:Histamine; D003061:Codeine